MX2023015205A - Composiciones veterinarias agradables. - Google Patents

Composiciones veterinarias agradables.

Info

Publication number
MX2023015205A
MX2023015205A MX2023015205A MX2023015205A MX2023015205A MX 2023015205 A MX2023015205 A MX 2023015205A MX 2023015205 A MX2023015205 A MX 2023015205A MX 2023015205 A MX2023015205 A MX 2023015205A MX 2023015205 A MX2023015205 A MX 2023015205A
Authority
MX
Mexico
Prior art keywords
palatable
veterinary compositions
pyrantel
efficacious
excipients
Prior art date
Application number
MX2023015205A
Other languages
English (en)
Inventor
Sharon Cruz Martin
Isabela Ewa Galeska
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2023015205A publication Critical patent/MX2023015205A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se dirige a una composición veterinaria masticable estable, eficaz y agradable que comprende como ingrediente activo un compuesto de isoxazolina de fórmula (I), una lactona macrocíclica estabilizada, pirantel y excipientes. (ver Fórmula).
MX2023015205A 2021-06-25 2022-06-24 Composiciones veterinarias agradables. MX2023015205A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21181879 2021-06-25
PCT/EP2022/067362 WO2022269042A1 (en) 2021-06-25 2022-06-24 Palatable veterinary compositions

Publications (1)

Publication Number Publication Date
MX2023015205A true MX2023015205A (es) 2024-01-18

Family

ID=76662391

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023015205A MX2023015205A (es) 2021-06-25 2022-06-24 Composiciones veterinarias agradables.

Country Status (11)

Country Link
EP (1) EP4358941A1 (es)
JP (1) JP2024523472A (es)
KR (1) KR20240025534A (es)
CN (1) CN117545473A (es)
AU (1) AU2022296860A1 (es)
BR (1) BR112023027372A2 (es)
CA (1) CA3222397A1 (es)
CL (1) CL2023003778A1 (es)
CO (1) CO2023017971A2 (es)
MX (1) MX2023015205A (es)
WO (1) WO2022269042A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803836D0 (en) 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
DK1731512T3 (en) 2004-03-05 2015-01-05 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide AND INSTRUMENTS FOR COMBATING HARMFUL ORGANISMS
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
AU2006203347C1 (en) 2006-05-15 2009-11-05 Wyeth Stabilised formulation
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
BRPI0923009B1 (pt) 2008-12-19 2018-07-17 Elanco Tiergesundheit Ag compostos de isoxazolina, composição para o controle de parasitas e uso de compostos de isoxazolina para o preparo de composição para o controle de parasitas
EA201401222A1 (ru) 2009-12-17 2015-10-30 Мериал Лимитед Противопаразитарные дигидроазоловые соединения и содержащие их композиции
AU2011236510A1 (en) 2010-04-08 2012-10-11 Zoetis Llc Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
CN113038937A (zh) * 2018-09-05 2021-06-25 硕腾服务有限责任公司 可口的抗寄生虫制剂
EP4208155A1 (en) * 2020-09-03 2023-07-12 Elanco Tiergesundheit AG Chewable formulations
WO2022051478A1 (en) * 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations

Also Published As

Publication number Publication date
JP2024523472A (ja) 2024-06-28
EP4358941A1 (en) 2024-05-01
CL2023003778A1 (es) 2024-08-30
KR20240025534A (ko) 2024-02-27
BR112023027372A2 (pt) 2024-03-12
AU2022296860A1 (en) 2023-12-14
WO2022269042A1 (en) 2022-12-29
CN117545473A (zh) 2024-02-09
CA3222397A1 (en) 2022-12-29
CO2023017971A2 (es) 2024-03-07

Similar Documents

Publication Publication Date Title
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
PH12021550338A1 (en) Palatable antiparasitic formulations
CO2023013469A2 (es) Derivados de fósforo como nuevos inhibidores de sos1
CO2020013876A2 (es) Nuevos derivados de quinolina
FI3592430T3 (fi) Antimikrobisia yhdisteitä, koostumuksia ja niiden käyttöjä
MX2023002671A (es) Formulaciones agradables.
MX2023003846A (es) Compuesto de bifenilo como inmunomodulador, metodo de preparacion del mismo y aplicacion del mismo.
MX2023009052A (es) Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo.
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
MX2022016263A (es) Derivados de ciclobutil-urea.
MX2023015205A (es) Composiciones veterinarias agradables.
WO2005065639A3 (en) Novel pharmaceutical compositions
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
MX2022014493A (es) Composiciones farmaceuticas inyectables y usos de las mismas.
BR112015025875A2 (pt) formulações de combinação veterinária estável de lactonas macrocíclicas e imidazotiazóis
MX2021005390A (es) Ingredientes farmaceuticos activos amorfos novedosos que comprenden carbonato de magnesio mesoporoso sustancialmente amorfo.
EA200970570A1 (ru) Макролидные соединения, обладающие противовоспалительной активностью
MX2024003015A (es) Nuevos derivados de quinolina.
AU2006203347C1 (en) Stabilised formulation
MX2023001572A (es) Formas farmaceuticas sólidas de palbociclib.
RU2205011C1 (ru) Фармацевтическая композиция с антибактериальной активностью
EA202091455A1 (ru) Стабилизированный фармацевтический состав, содержащий эверолимус
AR067320A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias
PL440066A1 (pl) Zastosowanie estru metylowego kwasu chinolino-6-karboksylowego w zwalczaniu roztoczy z gatunku Dermanyssus gallinae oraz środek roztoczobójczy
KR20150095282A (ko) 안정화된 페니실린 복합 현탁 제제